Trump White House accedes to FDA’s new vaccine safety guidelines

FDA Commissioner Stephen Hahn speaks at the briefing-room podium in August as President Donald Trump looks on.

Saul Loeb/Agence France-Presse/Getty Images

The White House endorsed the U.S. Food and Drug Administration’s plans for assessing whether a COVID-19 vaccine should be given widely, casting aside objections to requirements that would likely mean a shot won’t be cleared until after Election Day, people familiar with the matter said.


Originally published on MarketWatch

S&P 500 
$3,435.56  $7.56 
NASDAQ 100 
$11,665.37  $12.47 
Dow Jones Industrial Average 
$28,210.82  $97.97 
Apple Inc. 
$116.87  $0.6400 
Alphabet Inc. 
$1,593.31  $37.38 
MICROSOFT CORP 
179,92 €  1,50 € 
Tesla, Inc. 
$422.64  $0.7000 
Berkshire Hathaway Inc. 
$315,375.00  $1.00 
AbbVie Inc. 
$82.89  $1.36 
Costco Wholesale Corporation 
$377.82  $0.4900 
Smartsheet Inc. 
$56.31  $0.8400 
Zai Lab Limited 
$85.09  $2.45 
Western Digital Corporation 
$42.06  $0.6500 
NVIDIA Corporation 
$540.99  $4.83 
Gold Dec 20 
$1,928.20  $1.30 
Crude Oil Dec 20 
$40.02  $0.0100 
BTC/USD 
$12,959.63  $1.00 
Bitcoin Cash USD 
$260.43  $23.13 
LTC/USD 
$53.69  $6.64 
ETH/USD 
$396.78  $27.64 
Dogecoin USD 
$0.0026  $0.0000